Skip to main content

Table 5 Association between DM and other prognostic factors from univariate analysis

From: Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer

  

DM (−)

DM (+)

p value

Gender

Male

98

28

0.01 a

 

Female

31

2

 

Age, median (range)

 

64 (40–75)

64.5 (49–74)

0.44b

Performance status

0

72

18

0.51a

 

1

56

11

 
 

2

1

1

 

Stage

IIIA

70

16

0.92a

 

IIIB

59

14

 

Histology

Adenocarcinoma

71

16

0.76a

 

Squamous cell carcinoma

45

9

 
 

Large cell carcinoma

4

2

 
 

Others

9

3

 

Smoking history

Current or former

95

24

0.22a

 

Never

23

2

 
 

Unknown

11

4

 

Body mass index (BMI) (kg/m2)

BMI < 18.5

13

2

0.69a

 

18.5 ≤ BMI <25

94

22

 
 

25 ≤ BMI < 30

20

6

 
 

BMI ≥ 30

2

0

 

Laboratory parameters, median

   

b

 

White blood cell, cells/μl

7060 (2950–22310)

7275 (4290–13580)

0.67

 

Hemoglobin, g/l

13.4 (8.7–17.2)

13.6 (7.2–16.0)

0.49

 

Albumin, g/dl

4.1 (2.4–4.8)

4.0 (3.2–4.9)

0.71

 

AST, U/l

20 (11–60)

20.5 (11–50)

0.32

 

ALT, U/l

18 (5–67)

22.5 (9–63)

0.16

 

LDH, U/l

187 (121–591)

208 (135–1120)

0.05

 

Calcium, mg/dl

9.0 (7.6–10.6)

9.05 (8.2–9.9)

0.59

 

Creatinine, mg/dl

0.71 (0.4–1.28)

0.73 (0.48–1.23)

0.43

 

Glucose, mg/dl

100 (62–144)

118 (85–230)

<0.001

  1. DM Diabetes mellitus, AST Alanine aminotransferase, AST Aspartate aminotransferase, LDH Lactate dehydrogenase
  2. aFisher's exact test; bWilcoxon rank sum test; Boldfaced p-values are statistically significant (p < 0.05)